Трансляционная биомедицина

  • ISSN: 2172-0479
  • Индекс Хирша журнала: 16
  • Оценка цитируемости журнала: 5.91
  • Импакт-фактор журнала: 3.66
Индексировано в
  • Open J Gate
  • Журнал GenamicsSeek
  • ЖурналTOCs
  • ИсследованияБиблия
  • Глобальный импакт-фактор (GIF)
  • Китайская национальная инфраструктура знаний (CNKI)
  • CiteFactor
  • Шимаго
  • Библиотека электронных журналов
  • Справочник индексации исследовательских журналов (DRJI)
  • OCLC- WorldCat
  • Вызов запроса
  • Паблоны
  • МИАР
  • Комиссия по университетским грантам
  • Женевский фонд медицинского образования и исследований
  • Google Scholar
  • ШЕРПА РОМЕО
  • Секретные лаборатории поисковых систем
  • ResearchGate
Поделиться этой страницей

Абстрактный

Orthopaedic Research in United States during the Covid-19 Era

William Stetson

The quick and broad use of telemedicine across disciplines, including orthopaedics, was prompted by the coronavirus pandemic. In a short amount of time, newly approved telehealth practises have gone from being an experiment to the standard as a result of a series of circumstances, starting with payers, moving on to providers adoption, and then reciprocated by patients. The COVID-19 era is not the end of telemedicine, according to orthopaedic surgeons, but there are still a lot of long-term adjustments that payers, providers, and patients need to make if tele health is to continue. The purpose of this study is to describe the chain of events that led to the widespread adoption of telemedicine in orthopaedic clinics around the world, to show how irreversible its adoption is, and to spark discussion about next measures that may be taken to maintain its advantages.